
The Merkel cells, which are located at the base of the epidermis (the outermost layer of the skin), are the source of Merkel cell carcinoma (MCC), an uncommon and aggressive form of skin cancer. These cells contribute to touch perception and are linked to nerve endings. When MCC develops on sun-exposed skin, it usually appears as a rapidly growing, painless nodule on the face, head, or neck.
Due to its high level of aggression and ability to spread quickly to other regions of the body (metastasise), Merkel Cell Carcinoma (MCC) must be treated promptly. Treatment effectiveness and better results are more likely to occur when the earlier MCC is identified and treated. Postponing treatment might cause the cancer to spread, making it harder to manage and decreasing the chances of survival.
The patient's quality of life can be significantly enhanced, metastases can be avoided, and the possibility of recurrence can be reduced with early intervention, usually through surgery, radiation, or immunotherapy.
Early identification and treatment are crucial for MCC patients to have the best chance of recovery.
The exact cause of Merkel cell carcinoma (MCC) isn't completely understood, but several factors are involved in its development:
Causes
Risk Factors
Turkey has achieved notable progress in the diagnosis and management of Merkel Cell Carcinoma (MCC) by means of clinical research, immunotherapy, and multicentric investigations. Research has examined the contribution of particular viruses and UV exposure to the development of MCC, offering valuable information on the course of the disease. Immunotherapy has become a viable treatment option for advanced patients, especially when it comes to immune checkpoint inhibitors.
Taking proactive steps to shield your skin from damaging UV rays and preserving the general health of your skin is key to preventing MCC. Here are some tips:
Sun Protection
Regular Skin Checks
Healthy Lifestyle
Generally, Merkel cell carcinoma (MCC) treatment depends upon your overall health and its stage.
Mohn Surgery: It's a precise procedure that preserves as much healthy tissue as possible while removing the tumour and skin layers.
Wide Local Excision: This procedure removes the tumour and some surrounding healthy tissue.
Lymphadenectomy (Lymph Node Dissection): Lymph nodes are removed if the cancer has spread to them.
Immunotherapy : Immunotherapy restores your immune system to help fight the cancer.
Cost Start From USD 7420 - USD 42500Explore Options
Radiation Therapy- Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy.
Chemotherapy : Advanced or metastatic MCC may be treated with conventional chemotherapy medications, although these are less frequently utilised than immunotherapy or targeted therapy. Chemotherapy kills cancer cells that divide quickly and can be given orally or intravenously.
Cost Start From USD 7420 - USD 30000Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Istanbul, Turkey
Medicana Camlica Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Istanbul, Turkey
Architecture of the Hospital designed as per the comfort of patients-

Istanbul, Turkey
Acibadem Kadikoy Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Depending on the size of the tumour, the stage at diagnosis, and the extent of the cancer's spread, a person with Merkel Cell Carcinoma (MCC) may have a shorter life expectancy.
After radiation therapy and surgery, the prognosis for early-stage MCC is generally good, with a high survival rate. Despite recent dramatic improvements in survival rates due to immunotherapy and targeted treatments, the outlook for advanced or metastatic MCC can be more cautious.
Localised MCC has a 5-year survival rate of 60–80% overall, whereas advanced stages have a lower survival rate.
The neuroendocrine skin cancer known as Merkel cell carcinoma (MCC) is uncommon and highly aggressive. Its incidence is modest in Turkey however it has been rising recently.
MCC, or Merkel cell carcinoma, is characterised by its aggressiveness and quick proliferation. In addition to distant organs like the brain, liver, lungs, and bones, it can swiftly spread to neighbouring lymph nodes. Controlling the spread and enhancing results depend heavily on early detection and timely treatment.
Curing Merkel cell cancer (MCC) is possible, mainly if diagnosed early and treated. With a greater chance of successful treatment, the prognosis for localised MCC is better. However, when the cancer advances to more advanced stages, the likelihood of a cure declines.
There is little information on the prognosis of Merkel cell carcinoma (MCC), an uncommon but severe skin cancer, in Turkey. The importance of early detection and treatment is highlighted by the fact that 5-year survival rates vary significantly between countries according to the diagnosis stage.
The size, location, and presence or absence of lymph nodes of the tumour all affect recovery time following surgery for Merkel cell carcinoma (MCC) in Turkey.
Yes, Turkey has sophisticated diagnostic methods for Merkel cell cancer (MCC), such as sentinel lymph node biopsies, skin biopsies, and imaging tests, including CT and PET scans.
Turkey is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs when compared to several Western nations.
Yes, Turkey's healthcare system accepts patients from abroad and provides excellent MCC treatments at many clinics and hospitals.
Yes, many Turkish hospitals offer in-person and online consultations to foreign patients who want a second opinion.